[Heparin induced thrombocytopenia: how to manage when the patient is pregnant?].
Immune mediated heparin induced thrombocytopenia (HIT) remains the most common anti-body mediated, drug-induced thrombocytopenic disorder, and a leading cause of morbidity and mortality. Management of HIT in pregnant women remains uncertain. In this article, HIT in general, and special conditions and management issues in pregnant women discussed and the related literature reviewed.
Dikensoy
Ebru
E
Obstetrics and Gynecology, Vanderbilt University, Nashville, TN 37205, USA. dikensoy@yahoo.com
Dikensoy
Oner
O
Graves
Cornelia
C
Light
Richard W
RW
D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000139:chemically induced / Q000628:therapy*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*
D000925:Anticoagulants; D006493:Heparin